RGLS NASDAQ
Regulus Therapeutics Inc.
1W: -0.6%
1M: +3.2%
3M: +532.6%
1Y: +298.1%
3Y: +191.4%
5Y: -2.9%
$8.16
Last traded 2025-06-26 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+12.6% YoY
$-48M
Net Income
-51.5% YoY
$-43M
Free Cash Flow
-53.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-53.8%
ROA-50.3%
ROIC-807.9%
Valuation
P/E-10.0
P/B6.0
EV/EBITDA-1.1
Leverage
Debt/Equity0.02
Current Ratio16.31
Interest Cov.-510.0x
Quality Scores
Piotroski F3/9
Altman Z0.33
Beneish M0.00